BIOX Bioceres Crop Solutions Corp
Price (delayed)
$4.46
Market cap
$279.69M
P/E Ratio
223
Dividend/share
N/A
EPS
$0.02
Enterprise value
$536.16M
bioceres crop solutions corp., together with its subsidiaries, provides crop productivity solutions. the company operates through three segments: seed and integrated products, crop protection, and crop nutrition. the seed and
Highlights
The stock's price to earnings (P/E) is 22% less than its last 4 quarters average of 293.7
Bioceres Crop Solutions's quick ratio has increased by 19% YoY and by 9% QoQ
The net income has plunged by 93% YoY but it has grown by 2.4% from the previous quarter
Bioceres Crop Solutions's EPS has plunged by 94% YoY
BIOX's debt is up by 21% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of BIOX
Market
Valuations
Earnings
Shares outstanding
62.71M
Market cap
$279.69M
Enterprise value
$536.16M
Price to earnings (P/E)
223
Price to book (P/B)
0.91
Price to sales (P/S)
0.69
EV/EBIT
16.56
EV/EBITDA
9.73
EV/Sales
1.32
Revenue
$407.54M
Gross profit
$172.3M
Operating income
$32.71M
Net income
$1.5M
EBIT
$32.37M
EBITDA
$55.12M
Free cash flow
-$13.96M
Per share
Balance sheet
Liquidity
EPS
$0.02
EPS diluted
$0.02
Free cash flow per share
-$0.22
Book value per share
$4.93
Revenue per share
$6.49
TBVPS
$8.71
Total assets
$835.2M
Total liabilities
$488.87M
Debt
$285.64M
Equity
$309.55M
Working capital
$93.79M
Debt to equity
0.92
Current ratio
1.32
Quick ratio
1.01
Net debt/EBITDA
4.65
Margins
Efficiency
Dividend
EBITDA margin
13.5%
Gross margin
42.3%
Net margin
0.4%
Operating margin
8%
Return on assets
0.2%
Return on equity
0.5%
Return on invested capital
6.8%
Return on capital employed
5.9%
Return on sales
7.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BIOX stock price
How has the Bioceres Crop Solutions stock price performed over time
Intraday
-2.3%
1 week
6.44%
1 month
10.95%
1 year
-64.66%
YTD
-26.64%
QTD
-2.3%
Financial performance
How have Bioceres Crop Solutions's revenue and profit performed over time
Revenue
$407.54M
Gross profit
$172.3M
Operating income
$32.71M
Net income
$1.5M
Gross margin
42.3%
Net margin
0.4%
The net income has plunged by 93% YoY but it has grown by 2.4% from the previous quarter
BIOX's net margin has dropped by 92% year-on-year but it is up by 33% since the previous quarter
The operating income has contracted by 39% YoY and by 18% from the previous quarter
BIOX's operating margin is down by 32% YoY and by 12% QoQ
Growth
What is Bioceres Crop Solutions's growth rate over time
Valuation
What is Bioceres Crop Solutions stock price valuation
P/E
223
P/B
0.91
P/S
0.69
EV/EBIT
16.56
EV/EBITDA
9.73
EV/Sales
1.32
Bioceres Crop Solutions's EPS has plunged by 94% YoY
The stock's price to earnings (P/E) is 22% less than its last 4 quarters average of 293.7
BIOX's P/B is 76% lower than its 5-year quarterly average of 3.9 and 51% lower than its last 4 quarters average of 1.9
The equity has grown by 3% YoY
BIOX's P/S is 61% below its 5-year quarterly average of 1.8 and 46% below its last 4 quarters average of 1.3
The company's revenue fell by 10% YoY and by 8% QoQ
Efficiency
How efficient is Bioceres Crop Solutions business performance
The ROA has shrunk by 93% YoY
BIOX's return on equity has dropped by 93% year-on-year
BIOX's return on invested capital is down by 46% year-on-year and by 24% since the previous quarter
Bioceres Crop Solutions's ROS has decreased by 36% YoY and by 14% from the previous quarter
Dividends
What is BIOX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BIOX.
Financial health
How did Bioceres Crop Solutions financials performed over time
BIOX's total assets is 71% higher than its total liabilities
Bioceres Crop Solutions's quick ratio has increased by 19% YoY and by 9% QoQ
Bioceres Crop Solutions's current ratio has increased by 6% YoY and by 3.9% from the previous quarter
BIOX's debt is 8% smaller than its equity
BIOX's debt is up by 21% year-on-year and by 7% since the previous quarter
Bioceres Crop Solutions's debt to equity has increased by 16% YoY and by 7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.